Galera Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 5.59 million compared to USD 16.19 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.58 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1826 USD | -1.88% | -4.30% | +25.58% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Mar. 28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+25.58% | 10.12M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- GRTX Stock
- News Galera Therapeutics, Inc.
- Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023